N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid

C78H109BrN20O22S — CID 163196024

IUPACN-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid
SMILES[H]/N=C(\O)CCC1/C(O)=N\C(Cc2ccccc2)/C(O)=N\C(C(C)O)C(=O)N(C/C(O)=N/[H])CC(=O)N(C)CC(=O)OC(C)C(/N=C(\O)C(CS(=O)(=O)O)/N=C(\O)C(CCCN/C(N)=N/[H])/N=C(\O)C(Cc2c[nH]c3ccccc23)/N=C(\O)C(/N=C(\O)C(/N=C(\O)C2CCCN2C(=O)C(Cc2ccc(Br)cc2)/N=C(\O)C(C)/N=C/O)C(C)C)C(C)C)C(=O)N1C
InChIInChI=1S/C78H109BrN20O22S/c1-40(2)62(93-74(114)63(41(3)4)92-72(112)57-22-16-30-99(57)75(115)54(90-66(106)42(5)86-39-100)32-46-23-25-48(79)26-24-46)73(113)89-53(33-47-34-85-50-20-14-13-19-49(47)50)68(108)87-51(21-15-29-84-78(82)83)67(107)91-55(38-122(118,119)120)70(110)95-65-44(7)121-61(105)37-96(8)60(104)36-98(35-59(81)103)77(117)64(43(6)101)94-69(109)52(31-45-17-11-10-12-18-45)88-71(111)56(27-28-58(80)102)97(9)76(65)116/h10-14,17-20,23-26,34,39-44,51-57,62-65,85,101H,15-16,21-22,27-33,35-38H2,1-9H3,(H2,80,102)(H2,81,103)(H,86,100)(H,87,108)(H,88,111)(H,89,113)(H,90,106)(H,91,107)(H,92,112)(H,93,114)(H,94,109)(H,95,110)(H4,82,83,84)(H,118,119,120)
InChIKeyGFIASASVBVIMRU-UHFFFAOYSA-N
MW1790.82 g/mol
LogP5.60
Rot. Bonds36

About N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid

N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid (PubChem CID 163196024) has the molecular formula C78H109BrN20O22S and a molecular weight of 1790.82 g/mol. Its IUPAC name is N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid.

Molecular Properties

Compound NameN-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid
PubChem CID163196024
Molecular FormulaC78H109BrN20O22S
Molecular Weight1790.82 g/mol
Exact Mass1788.69
IUPAC NameN-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid
SMILES[H]/N=C(\O)CCC1/C(O)=N\C(Cc2ccccc2)/C(O)=N\C(C(C)O)C(=O)N(C/C(O)=N/[H])CC(=O)N(C)CC(=O)OC(C)C(/N=C(\O)C(CS(=O)(=O)O)/N=C(\O)C(CCCN/C(N)=N/[H])/N=C(\O)C(Cc2c[nH]c3ccccc23)/N=C(\O)C(/N=C(\O)C(/N=C(\O)C2CCCN2C(=O)C(Cc2ccc(Br)cc2)/N=C(\O)C(C)/N=C/O)C(C)C)C(C)C)C(=O)N1C
InChIInChI=1S/C78H109BrN20O22S/c1-40(2)62(93-74(114)63(41(3)4)92-72(112)57-22-16-30-99(57)75(115)54(90-66(106)42(5)86-39-100)32-46-23-25-48(79)26-24-46)73(113)89-53(33-47-34-85-50-20-14-13-19-49(47)50)68(108)87-51(21-15-29-84-78(82)83)67(107)91-55(38-122(118,119)120)70(110)95-65-44(7)121-61(105)37-96(8)60(104)36-98(35-59(81)103)77(117)64(43(6)101)94-69(109)52(31-45-17-11-10-12-18-45)88-71(111)56(27-28-58(80)102)97(9)76(65)116/h10-14,17-20,23-26,34,39-44,51-57,62-65,85,101H,15-16,21-22,27-33,35-38H2,1-9H3,(H2,80,102)(H2,81,103)(H,86,100)(H,87,108)(H,88,111)(H,89,113)(H,90,106)(H,91,107)(H,92,112)(H,93,114)(H,94,109)(H,95,110)(H4,82,83,84)(H,118,119,120)
InChIKeyGFIASASVBVIMRU-UHFFFAOYSA-N
XLogP5.60
TPSA673.89 Ų
H-Bond Donors20
H-Bond Acceptors22
Rotatable Bonds36
Heavy Atoms122
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001790.82
LogP ≤ 55.60
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid?
The IUPAC name of N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid (CID 163196024) is N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid.
What is the SMILES notation for N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid?
The canonical SMILES for N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid is [H]/N=C(\O)CCC1/C(O)=N\C(Cc2ccccc2)/C(O)=N\C(C(C)O)C(=O)N(C/C(O)=N/[H])CC(=O)N(C)CC(=O)OC(C)C(/N=C(\O)C(CS(=O)(=O)O)/N=C(\O)C(CCCN/C(N)=N/[H])/N=C(\O)C(Cc2c[nH]c3ccccc23)/N=C(\O)C(/N=C(\O)C(/N=C(\O)C2CCCN2C(=O)C(Cc2ccc(Br)cc2)/N=C(\O)C(C)/N=C/O)C(C)C)C(C)C)C(=O)N1C.
What is the InChIKey of N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid?
The InChIKey is GFIASASVBVIMRU-UHFFFAOYSA-N. The full InChI is InChI=1S/C78H109BrN20O22S/c1-40(2)62(93-74(114)63(41(3)4)92-72(112)57-22-16-30-99(57)75(115)54(90-66(106)42(5)86-39-100)32-46-23-25-48(79)26-24-46)73(113)89-53(33-47-34-85-50-20-14-13-19-49(47)50)68(108)87-51(21-15-29-84-78(82)83)67(107)91-55(38-122(118,119)120)70(110)95-65-44(7)121-61(105)37-96(8)60(104)36-98(35-59(81)103)77(117)64(43(6)101)94-69(109)52(31-45-17-11-10-12-18-45)88-71(111)56(27-28-58(80)102)97(9)76(65)116/h10-14,17-20,23-26,34,39-44,51-57,62-65,85,101H,15-16,21-22,27-33,35-38H2,1-9H3,(H2,80,102)(H2,81,103)(H,86,100)(H,87,108)(H,88,111)(H,89,113)(H,90,106)(H,91,107)(H,92,112)(H,93,114)(H,94,109)(H,95,110)(H4,82,83,84)(H,118,119,120).
What are the key properties of N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid?
N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid has a molecular weight of 1790.82 g/mol, XLogP of 5.60, 36 rotatable bonds, 20 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[1-[1-[1-[1-[[12-benzyl-11,14-dihydroxy-9-(1-hydroxyethyl)-7-(2-hydroxy-2-iminoethyl)-15-(3-hydroxy-3-iminopropyl)-4,16,19-trimethyl-2,5,8,17-tetraoxo-1-oxa-4,7,10,13,16-pentazacyclononadeca-10,13-dien-18-yl]imino]-1-hydroxy-3-sulfopropan-2-yl]imino-5-carbamimidamido-1-hydroxypentan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]imino-1-hydroxy-3-methylbutan-2-yl]-1-[3-(4-bromophenyl)-2-[[1-hydroxy-2-(hydroxymethylideneamino)propylidene]amino]propanoyl]pyrrolidine-2-carboximidic acid is sourced from PubChem (CID 163196024), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).